DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,129 filers reported holding DANAHER CORPORATION in Q1 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,860,000 | -7.2% | 69,438 | -6.0% | 0.16% | -7.4% |
| Q1 2017 | $6,317,000 | -6.6% | 73,859 | -15.0% | 0.18% | -9.3% |
| Q4 2016 | $6,762,000 | -2.1% | 86,870 | -1.4% | 0.19% | -2.5% |
| Q3 2016 | $6,905,000 | -8.6% | 88,084 | +17.8% | 0.20% | -12.3% |
| Q2 2016 | $7,551,000 | +9.0% | 74,767 | +2.4% | 0.23% | +14.1% |
| Q1 2016 | $6,929,000 | -13.2% | 73,042 | -15.0% | 0.20% | -13.5% |
| Q4 2015 | $7,982,000 | +13.0% | 85,937 | +3.7% | 0.23% | +5.0% |
| Q3 2015 | $7,064,000 | -1.4% | 82,902 | -0.9% | 0.22% | +6.3% |
| Q2 2015 | $7,164,000 | +3.2% | 83,697 | +2.4% | 0.21% | +5.1% |
| Q1 2015 | $6,940,000 | +1.2% | 81,742 | +2.2% | 0.20% | -1.5% |
| Q4 2014 | $6,855,000 | +20.5% | 79,977 | +6.8% | 0.20% | +3.1% |
| Q3 2014 | $5,689,000 | -1.1% | 74,876 | +2.5% | 0.19% | +4.9% |
| Q2 2014 | $5,751,000 | -11.4% | 73,041 | -15.6% | 0.18% | -7.5% |
| Q1 2014 | $6,494,000 | -11.8% | 86,582 | -9.3% | 0.20% | -7.0% |
| Q4 2013 | $7,366,000 | -15.0% | 95,412 | -23.7% | 0.21% | +2.4% |
| Q3 2013 | $8,670,000 | +12.2% | 125,077 | +2.5% | 0.21% | +3.0% |
| Q2 2013 | $7,725,000 | – | 122,038 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |